Just Ahead of Flu Season, FDA Approves First mRNA Vaccine for Older Adults
The FDA approved a new mRNA flu vaccine for older adults ahead of the upcoming 2026–2027 flu season. fotostorm/E+/Getty Images The Food and Drug Administration (FDA) has approved a new mRNA flu vaccine for older adults. The new flu shot, called mFLUSIVA, was found to be effective in clinical trials in preventing serious illness in people ages 50 to 64. The vaccine was also given accelerated…
We haven't written up this one. Healthline News has the full story — the link below goes straight to it.
